Estados financieros detallados de Matinas BioPharma Holdings, Inc. (MTNB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.17, MTNB presenta beneficios negativos (P/E no significativo) y un ROE del -181.45%. La capitalización bursátil es de $1M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | $149687 | $119750 | $89812 | $158333 | $33000 | $3.2M | $1.1M | 0 | 0 |
| Coste de Ventas | $52644 | $9.0M | $6.8M | $11.2M | $14.4M | $14.6M | $16.7M | $941000 | $972000 | $456000 |
| Beneficio Bruto | -$52644 | -$8.9M | -$6.7M | -$11.1M | -$14.2M | -$14.6M | -$13.5M | $155000 | -$972000 | -$456000 |
| I+D | $3.9M | $9.0M | $6.8M | $11.2M | $14.4M | $14.6M | $16.7M | $14.5M | $11.4M | $85000 |
| Generales y Administrativos | $4.3M | $7.6M | $8.0M | $7.8M | $10.0M | $10.2M | $11.1M | $9.4M | $7.8M | $6.9M |
| Gastos Operativos | $8.3M | $16.7M | $14.8M | $7.8M | $10.0M | $10.2M | $11.1M | $23.9M | $19.2M | $6.5M |
| Beneficio Operativo | -$8.3M | -$16.5M | -$14.6M | -$18.9M | -$24.2M | -$24.7M | -$24.6M | -$23.8M | -$20.2M | -$7.0M |
| EBITDA | -$8.2M | -$16.4M | -$14.4M | -$18.6M | -$23.9M | -$23.0M | -$20.6M | -$22.0M | -$19.2M | -$9.9M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$7.6M | -$15.8M | -$14.6M | -$17.4M | -$22.4M | -$23.3M | -$21.0M | -$22.9M | -$24.3M | -$10.3M |
| Impuestos | 0 | -$356956 | -$506920 | 0 | 0 | 0 | 0 | 0 | -$80000 | 0 |
| Beneficio Neto | -$7.6M | -$15.5M | -$14.1M | -$17.4M | -$22.4M | -$23.3M | -$21.0M | -$22.9M | -$24.3M | -$10.3M |
| BPA | $-6.59 | $-8.56 | $-7.18 | $-5.37 | $-5.23 | $-5.04 | $-3.00 | $-5.28 | $-4.98 | $-2.00 |
| BPA Diluido | $-6.59 | $-8.56 | $-7.18 | $-5.37 | $-5.23 | $-5.04 | $-3.00 | $-5.28 | $-4.98 | $-2.00 |
| Acciones en Circulación (Diluidas) | $1.2M | $1.8M | $2.0M | $2.9M | $3.9M | $4.2M | $4.3M | $4.3M | $4.9M | $5.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$114000 | $85000 | -$74000 | -$4000 |
| Beneficio Operativo | -$1.6M | -$1.6M | -$1.9M | -$1.6M |
| EBITDA | -$2.0M | -$604000 | -$1.8M | -$1.8M |
| Beneficio Neto | -$2.1M | -$1.9M | -$1.9M | -$1.3M |
| BPA | $-0.40 | $-0.30 | $-0.30 | $-0.21 |
| BPA Diluido | $-0.40 | $-0.30 | $-0.30 | $-0.21 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $4.1M | $7.3M | $12.4M | $22.2M | $12.4M | $21.0M | $6.9M | $4.8M | $7.3M | $4.0M |
| Inversiones a Corto | 0 | 0 | 0 | $5.6M | $46.2M | $28.6M | $21.9M | $9.0M | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $4.6M | $8.0M | $13.1M | $29.9M | $61.6M | $51.0M | $34.5M | $15.5M | $8.0M | $4.1M |
| Inmovilizado Material | $356000 | $1.6M | $2.0M | $5.6M | $4.9M | $5.8M | $5.7M | $5.0M | $2.2M | $673000 |
| Fondo de Comercio | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | 0 | 0 |
| Activos Intangibles | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $2.3M | $2.3M |
| Activos Totales | $9.8M | $14.4M | $19.9M | $40.2M | $71.0M | $61.3M | $78.9M | $25.1M | $12.6M | $7.2M |
| Cuentas por Pagar | $475602 | $582867 | $295652 | $679310 | $349941 | $937000 | $618000 | $514000 | $95000 | $315000 |
| Deuda a Corto | $118046 | $170236 | $199842 | 0 | 0 | 0 | $569000 | 0 | 0 | $696000 |
| Pasivos Corrientes | $1.4M | $2.2M | $2.8M | $3.1M | $3.6M | $4.3M | $4.3M | $2.6M | $2.7M | $1.5M |
| Deuda a Largo | 0 | 0 | 0 | $3.75B | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $2.7M | $3.7M | $3.8M | $7.2M | $7.2M | $8.8M | $42.2M | $5.9M | $5.1M | $2.4M |
| Reservas | -$35.2M | -$51.3M | -$65.9M | -$84.4M | -$107.5M | -$131.6M | -$152.6M | -$175.6M | -$199.8M | -$210.8M |
| Patrimonio Neto | $7.1M | $10.7M | $16.1M | $33.1M | $63.7M | $52.5M | $36.6M | $19.2M | $7.6M | $4.8M |
| Deuda Total | $144428 | $264894 | $390743 | $4.2M | $3.8M | $4.7M | $4.1M | $3.6M | $2.9M | $1.4M |
| Deuda Neta | -$4.0M | -$7.0M | -$12.1M | -$23.5M | -$54.9M | -$44.9M | -$24.7M | -$10.2M | -$4.4M | -$2.6M |
| Capital Circulante | $3.1M | $5.7M | $10.2M | $26.8M | $58.0M | $46.6M | $30.2M | $12.9M | $5.4M | $2.6M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $5.4M | $4.0M | $2.4M | $761000 |
| Activos Totales | $9.7M | $7.2M | $5.9M | $3.4M |
| Pasivos Totales | $3.2M | $2.4M | $2.9M | $1.6M |
| Patrimonio Neto | $6.5M | $4.8M | $3.0M | $1.8M |
| Deuda Total | $2.3M | $1.4M | $1.2M | $6000 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$7.6M | -$15.5M | -$14.1M | -$17.4M | -$22.4M | -$23.3M | -$21.0M | -$22.9M | -$24.3M | -$10.3M |
| Amortizaciones | $52644 | $100605 | $218308 | $780816 | $774587 | $781000 | $898000 | $941000 | $972000 | $452000 |
| Compensación en Acciones | $1.5M | $3.6M | $3.8M | $3.0M | $4.6M | $4.3M | $5.2M | $4.9M | $3.2M | $1.0M |
| Cambio en Capital Circulante | -$93787 | $528574 | $160238 | -$492066 | -$508688 | $1.5M | -$4.8M | $1.7M | -$131000 | -$1.5M |
| Flujo de Caja Operativo | -$6.1M | -$11.5M | -$10.3M | -$14.1M | -$17.4M | -$15.2M | -$19.2M | -$15.3M | -$15.9M | -$7.0M |
| Inversiones (CapEx) | 0 | -$942180 | -$535916 | -$405604 | -$5749 | -$260000 | -$892000 | -$218000 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | $8.5M | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | -$4.39B | -$608.3M | -$587.1M | -$2.23B | -$682.8M | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$6.1M | -$12.4M | -$10.9M | -$14.5M | -$17.4M | -$15.5M | -$20.0M | -$15.5M | -$15.9M | -$7.0M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.5M | -$1.5M | -$1.6M | -$1.8M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$1.5M | -$1.5M | -$1.6M | -$1.8M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $253000 | $217000 | 0 | $104000 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | -20.0% | -25.0% | +76.3% | -79.2% | +9560.6% | -65.6% | -100.0% | |
| Crecimiento Beneficio Neto (anual) | | -103.8% | +9.1% | -23.4% | -29.2% | -3.7% | +9.8% | -9.3% | -5.7% | +57.3% |
| Crecimiento BPA (anual) | | -29.9% | +16.1% | +25.2% | +2.6% | +3.6% | +40.5% | -76.0% | +5.7% | +59.8% |
| Cambio en Acciones (anual) | | +56.9% | +8.4% | +48.0% | +35.6% | +6.7% | +3.2% | +0.2% | +12.0% | +12.5% |
| Crecimiento FCF (anual) | | -102.7% | +12.5% | -33.5% | -19.8% | +10.9% | -29.5% | +22.7% | -2.5% | +55.9% |
| Margen Bruto | | -5919.6% | -5568.0% | -12409.0% | -8968.8% | -44090.9% | -423.1% | 14.1% | | |
| Margen Operativo | | -11024.6% | -12230.9% | -21067.4% | -15288.4% | -74954.5% | -771.3% | -2168.4% | | |
| Margen EBITDA | | -10957.4% | -12048.6% | -20701.3% | -15105.2% | -69706.1% | -647.5% | -2007.4% | | |
| Margen Neto | | -10345.9% | -11760.4% | -19343.4% | -14177.0% | -70554.5% | -658.6% | -2093.2% | | |
| Margen FCF | | -8285.0% | -9066.5% | -16142.2% | -10972.8% | -46918.2% | -628.9% | -1413.9% | | |
| Tasa Impositiva Efectiva | -0.0% | 2.3% | 3.5% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.3% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-5.31 | $-6.85 | $-5.53 | $-4.99 | $-4.41 | $-3.68 | $-4.62 | $-3.57 | $-3.26 | $-1.28 |
| Dividendo por Acción | $3810.44 | $336.19 | $299.25 | $769.46 | $173.39 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.2M | $1.8M | $2.0M | $2.9M | $3.9M | $4.2M | $4.3M | $4.3M | $4.9M | $5.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -181.45% |
| Rentabilidad sobre capital invertido | -323.22% |
| Rentabilidad sobre activos | -214.21% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 0.85 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -42.88 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -10.62 | -6.78 | -4.14 | -21.14 | -13.00 | -10.02 | -8.33 | -2.05 | -0.10 | -0.29 |
| P/VC | 11.29 | 9.83 | 3.62 | 9.97 | 4.20 | 4.04 | 2.96 | 2.44 | 0.33 | 0.66 |
| P/V | 0.00 | 701.14 | 487.44 | 3669.81 | 1691.22 | 6432.73 | 34.00 | 42.86 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | -5919.6% | -5568.0% | -12409.0% | -8968.8% | -44090.9% | -423.1% | 14.1% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | -11024.6% | -12230.9% | -21067.4% | -15288.4% | -74954.5% | -771.3% | -2168.4% | 0.0% | 0.0% |
| Margen Neto | 0.0% | -10345.9% | -11760.4% | -19343.4% | -14177.0% | -70554.5% | -658.6% | -2093.2% | 0.0% | 0.0% |